Jove
Visualize
Contact Us

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

18.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

5.5K
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
5.5K
Mitochondrial Membranes01:45

Mitochondrial Membranes

16.5K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.5K
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

3.5K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Savinase-functionalised oxidative drug-loaded nanocarriers enhance the treatment of solid colorectal tumours in a 3D cell culture model.

Journal of materials chemistry. B·2025
Same author

Dual surface functionalised curcumin-shellac nano-delivery system with enhanced antimicrobial action.

RSC advances·2025
Same author

3D structured capillary cell suspensions aided by aqueous two-phase systems.

Journal of materials chemistry. B·2024
Same author

Enhanced anticancer effect of lysozyme-functionalized metformin-loaded shellac nanoparticles on a 3D cell model: role of the nanoparticle and payload concentrations.

Biomaterials science·2024
Same author

Stimulus triggered release of actives from composite microcapsules based on sporopollenin from <i>Lycopodium clavatum</i>.

RSC advances·2024
Same author

Enhancing an Oxidative "Trojan Horse" Action of Vitamin C with Arsenic Trioxide for Effective Suppression of KRAS-Mutant Cancers: A Promising Path at the Bedside.

Cells·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 7, 2026

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
08:02

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform

Published on: November 7, 2013

13.3K

Emerging nano-delivery systems for targeting mitochondria.

Agata N Burska1,2, Kristina E Raish1, Dinmukhamet Bayandy3

  • 1National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan.

Nanoscale
|December 22, 2025
PubMed
Summary

Mitochondria-targeting nanosystems offer a novel therapeutic strategy for various diseases by delivering drugs directly to these organelles. This nanotechnology approach holds promise for advancing innovative treatments by addressing mitochondrial dysfunction.

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.9K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K

Related Experiment Videos

Last Updated: Jan 7, 2026

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
08:02

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform

Published on: November 7, 2013

13.3K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.9K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Mitochondrial Biology

Background:

  • Mitochondrial dysfunction is implicated in numerous diseases, including cancer.
  • Mitochondria play crucial roles in cellular function and disease pathology.
  • Targeting mitochondria presents a promising therapeutic avenue.

Purpose of the Study:

  • To comprehensively analyze mitochondria-targeting nanosystems for disease treatment.
  • To explore the mechanisms of mitochondrial dysfunction and nanotechnology's role.
  • To assess the therapeutic potential and challenges of these nanosystems.

Main Methods:

  • Review of recent developments in mitochondria-targeting nanosystems.
  • Analysis of design principles and applications of these systems.
  • Evaluation of current limitations and future research directions.

Main Results:

  • Nanotechnology provides an innovative platform for targeted mitochondrial delivery.
  • Mitochondria-targeting nanosystems show potential for treating diverse diseases.
  • Understanding mitochondrial biology is key to developing effective nanotherapies.

Conclusions:

  • Mitochondria-targeting nanosystems represent a promising frontier in nanomedicine.
  • Overcoming current challenges is essential for expanding their clinical applications.
  • The synergy between mitochondrial biology and nanotechnology can drive innovative disease treatments.